Nurse Practitioner in Unalaska, AK Accepting Medicare
4 Nurse Practitioner nurses found. Showing 1 - 4
 Mrs. Kristina M Jones, APRN-CNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 34 Lavelle Ct #a, Unalaska, AK 99685 Phone: 907-581-2742 |
 Robert W Gneiting, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 34 Lavelle Court, Unalaska, AK 99685 Phone: 907-581-1202 Fax: 907-581-2331 |
Mrs. Beatriz Elizabeth Dietrick, ANP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 34 Lavalle Ct, Unalaska, AK 99685 Phone: 907-581-1202 |
Laura Ann Ballou, FNP-BC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 34 Lavelle Ct, Unalaska, AK 99685 Phone: 907-581-1202 Fax: 907-581-4897 |
News Archive
Researchers identify possible genetic basis for coronary artery disease
For many people, coronary artery disease, or CAD—the buildup of plaque in the heart's arteries—is an unfortunate part of aging. By studying the genetic makeup of those who manage to maintain clear arteries into old age, researchers have identified a possible genetic basis for the disease, as well as potential new opportunities to prevent it.
New study shows women with ADHD likely to have many mental, physical health problems
Women with ADHD are much more likely to have a wide range of mental and physical health problems in comparison to women without ADHD, according to a new study from researchers at the University of Toronto.
Researchers develop new strategy to control inflammation without serious side effects
A potential new strategy to developing new drugs to control inflammation without serious side effects has been found by Georgia State University researchers and international colleagues.
Quethera receives seed investment funding to develop gene therapy for glaucoma
Quethera, a gene therapy company developing a treatment for glaucoma that could prevent blindness, has received seed investment funding led by Midven's Rainbow Seed Fund alongside co-investor Cambridge Enterprise, the commercialisation arm of the University of Cambridge, to continue pre-clinical development of their therapy.
› Verified 5 days ago